TREK-1 Antibodies

Santa Cruz Biotechnology offers a broad range of TREK-1 monoclonal antibodies for advanced research in ion channel biology. TREK-1 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TREK-1, also known as KCNK2, is a member of the two-pore domain potassium channel family and plays a crucial role in maintaining cellular excitability and regulating neuronal activity. TREK-1 functions are essential in various physiological processes, including pain sensation, cardiovascular regulation, and neuroprotection. Research focused on TREK-1 can provide insights into potential therapeutic targets for neurological disorders and other conditions. Scientists studying ion channel biology rely on TREK-1 monoclonal antibodies to uncover new mechanisms and pathways. TREK-1 monoclonal antibodies enable detailed examination of potassium channel distribution and function across different tissue types. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of ion channel biology and its impact on human health.